Abbvie, Androgel partner owe $488 million in antitrust case: U.S. judge

(Reuters) - A U.S. judge on Friday found that Abbvie Inc used sham litigation to illegally prevent generic versions of testosterone gel AndroGel from getting to market and ordered the drugmaker and its partner to pay $488 million.

from Reuters: Health News https://ift.tt/2tS15yX